Oxford BioMedica looks to move on from a challenging 2008

pharmafile | March 13, 2009 | News story | Sales and Marketing |  Oxford BioMedica, biotech 

Related Content

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

Arkin Capital has announced the closing of Arkin Bio Ventures III, a $100m fund designed …

Cellbyte raises $2.75m to fund pharma drug launch platform

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of …

Lilly opens fourth US Gateway Labs site

Eli Lilly has opened its newest Lilly Gateway Labs (LGL) site in San Diego, California, …

The Gateway to Local Adoption Series

Latest content